LOS ANGELES, Feb. 13, 2018 -- You just started dating someone and you're really hitting it off. Except something is just not quite right. Could they have a drinking problem?
Contrary to popular belief, not all alcoholics exhibit the more obvious signs of having a drinking problem such as frequent blackouts, extreme mood swings and embarrassing behavior. For many high functioning alcoholics, the signs are much more subtle.
Lindsay Killam, Clinical Program Director for Alavida Health, a science-based company that combines medication, behavioral therapy and technology to help people decrease or stop consumption of alcohol, offers 5 subtle warning signs that you might be dating someone with a drinking problem—and what to do about it:
1. They consistently drink before and after social events. They always feel the need to "warm up" before going out or need to continue drinking after getting home.
2. They feel guilty about drinking. This is an indicator that a person is not proud of their behavior, that they have disappointed others, or themselves. They continue to drink despite social or emotional consequences.
3. They have a high tolerance for alcohol. They can have several drinks and not exhibit any signs of being intoxicated.
4. They use it to cope. The person needs alcohol to relax or to deal with stress. They use alcohol instead of healthier options.
5. They hide it. If they try hiding their drinking from you or others.
According to Lindsay Killam, "Addiction is a learned behavior. Everyone has the ability to unlearn dysfunctional behaviour and reinforce healthier coping. When talking to a loved one it is important to come from a place of empathy. A nonjudgmental approach invites conversation and understanding. Be clear about what you observe as the consequences of their behaviour and at the same time let them know that you believe in their potential. Finally, let them know that they can decide how change looks whether that be controlled drinking or abstinence."
About Alavida
Alavida Health is a science-based treatment program that combines non-addictive medication, behavioral therapy and technology to help people decrease or stop their consumption of alcohol. Alavida clients work with their doctor and therapist for typically four to six months and can access their doctors in person or virtually, making the access barrier-free. Available in North America since 2016, Alavida currently has offices in Canada and the USA. The treatment model has a success rate of over 75 percent, in line with a clinical study and 20 years of ongoing practice conducted in Finland. More information about Alavida and how treatment works can be found at www.alavida.co.
Contact:
Binu Koshy
Media Relations
P: 905-617-1988
E: [email protected]
Elliot Stone
Chief Executive Officer
P: 888-315-7509
E: [email protected]


Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
How Marco Pharma International Preserves German Homeopathic Traditions in America
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release 



